IN2014CN00626A - - Google Patents

Info

Publication number
IN2014CN00626A
IN2014CN00626A IN626CHN2014A IN2014CN00626A IN 2014CN00626 A IN2014CN00626 A IN 2014CN00626A IN 626CHN2014 A IN626CHN2014 A IN 626CHN2014A IN 2014CN00626 A IN2014CN00626 A IN 2014CN00626A
Authority
IN
India
Prior art keywords
subject
histolytica
mutant
infection
risk
Prior art date
Application number
Other languages
English (en)
Inventor
Rahmah Binti Noordin
Boon Huat Lim
Zeehaida Mohamed
Nurulhasanah Othman
Weng Kin Wong
Zi Ning Tan
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Publication of IN2014CN00626A publication Critical patent/IN2014CN00626A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
IN626CHN2014 2011-07-07 2011-07-20 IN2014CN00626A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2011003202A MY172643A (en) 2011-07-07 2011-07-07 Diagnosis of entamoeba histolytica
PCT/MY2011/000172 WO2013006024A1 (en) 2011-07-07 2011-07-20 Diagnosis of entamoeba histolytica

Publications (1)

Publication Number Publication Date
IN2014CN00626A true IN2014CN00626A (es) 2015-04-03

Family

ID=47437247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN626CHN2014 IN2014CN00626A (es) 2011-07-07 2011-07-20

Country Status (7)

Country Link
BR (1) BR112014000135A2 (es)
CO (1) CO6940378A2 (es)
IN (1) IN2014CN00626A (es)
MX (1) MX358619B (es)
MY (1) MY172643A (es)
WO (1) WO2013006024A1 (es)
ZA (1) ZA201400469B (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130417A (en) * 1990-04-30 1992-07-14 Washington University Entamoeba histolytical immunogenic protein and cdna clone
MX9206019A (es) * 1992-10-20 1994-04-29 Univ Autonoma De Nuevo Leon Procedimiento para la preservacion de moleculas antigenicas sin el uso de inhibidores enzimaticos.

Also Published As

Publication number Publication date
MY172643A (en) 2019-12-07
WO2013006024A1 (en) 2013-01-10
BR112014000135A2 (pt) 2018-06-19
CO6940378A2 (es) 2014-05-09
ZA201400469B (en) 2015-08-26
MX2014000007A (es) 2015-02-12
MX358619B (es) 2018-08-28

Similar Documents

Publication Publication Date Title
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
BR112014031365A2 (pt) métodos de detectar doenças ou condições
EP4234583A3 (en) Evaluation and treatment of bradykinin-mediated disorders
MX2015004640A (es) Anticuerpos monoclonales y metodos de deteccion para enzimas que confieren resistencia a la fosfinotricina n acetil transferasa.
ES2570380T3 (es) Método para determinar la aptitud de inhibidores de EZH2 humano en tratamiento
EP2829881A3 (en) Diagnostic for colorectal cancer
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EP2569635A4 (en) METHODS OF DIAGNOSING AND TREATING ENCEPHALITY OR EPILEPSY
MX336109B (es) Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo.
MX357429B (es) Predictores para el tratamiento del cáncer.
ZA201402460B (en) Assembly for determining the presence or absence of an analyte in a blood sample and analysis unit comprising such an assembly
EP2738554A4 (en) BIOINFORMATICS PLATFORM FOR HIGH-PURITY IDENTIFICATION AND QUANTIFICATION OF N-GLYCOPEPTIDE
MX2021009528A (es) Prueba de diagnostico basada en fragmento de rgma.
IN2015DN01501A (es)
EA201171239A1 (ru) Способ детекции типа паппиломавируса человека (hpv)
SG10201806729VA (en) Novel assay to detect human periostin
MX2016012278A (es) Deteccion temprana de preeclampsia.
PH12014501445B1 (en) Detection of human umbilical cord tissue-derived cells
AU2013231230A8 (en) Method for selecting or identifying a subject for V1B antagonist therapy
NZ720608A (en) Β-glucan assay methods
MY192159A (en) Method for detecting neutralizing antibodies against recombinant human insulin in human serum
MX2015007494A (es) Metodo para diagnosticar leucodistrofia metacromatica.
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
IN2014CN00626A (es)
CL2009001907A1 (es) Metodo de deteccion precoz de cancer gastrico que comprende detectar la presencia de marcadores especificos de cancer gastrico en muestras de plasma.